« Back to Training Calendar

Genetics Conference 2013
Genetics to Genomics: The Future and Beyond!

June 22, 2013: Dallas, TX at the Westin Galleria

June 29, 2013: Austin, TX at the AT&T Conference Center

July 13, 2013: San Antonio, TX at the Grand Hyatt

Texas Department of State Health Services (DSHS) Newborn Screening Unit and Genetics has partnered with Cardea to bring you our 3rd Annual Genetics Conference!


What is genomics?

According to the CDC, the term genomics describes the study of all genes in the human body, as well as their interactions with each other and the environment. Why is it important to know about genomics? Full genomic sequencing is becoming more common as testing becomes less expensive. Clinicians need to know why and when to order tests and what the tests can and cannot do for their patients. Clinicians must be prepared for test results that raise ethical dilemmas. Attend the Genetics Conference 2013 to explore these complex issues.

Agenda

Download the conference agendas:

» Dallas Genetics agenda

» Austin Genetics agenda

» San Antonio Genetics agenda

Register Now!

Click on a link below to register. Before registering you will be required to create or log in to your profile.

Registration is closed.

What attendees had to say!

  • Informative and wonderful speakers- genetics is such a complex field- great information about emerging therapies for diagnosis that in the past had no therapy—it gives families/patients hope
  • Good job!! This was a well thought out conference with high quality speakers. When is the next one??
  • This topic of Genetics is always the one we learn the least about and this conference helped with learning or refreshing this knowledge. Thank you!

Questions?

For more information email workshop@cardeaservices.org or call 512-474-2166. Contact us if you would like updates on these events.

Tens of thousands of Texas babies are born each year with genetic disorders.

Attend the Genetics Conference 2013 to learn about advances in genetics and genomics, including clinical implications of whole genome sequencing. Topics will include when testing is applicable, the impact on your patients, the ethical dilemmas involved in disclosing whole genome sequencing test results, and more.

Objectives

At the end of this training, participants will be able to:

  • Explain why genomics is an important topic for the clinical practice;
  • Give examples of recent advances in next generation sequencing;
  • Discuss how next generation sequencing can affect patient outcomes;
  • Explain when next generation sequencing is appropriate;
  • Describe how epigenetics can impact patient health;
  • Identify ethical challenges of managing genetic diagnoses; and
  • Discuss multiple perspectives on how advances in genetic testing and treatment affect patient care.

Who should attend?

Physicians, nurses, nurse practitioners, PAs, CNMs, genetic counselors and others who may encounter patients with genetic disorders. Fields include, but are not limited to general and family practice, pediatrics, OB/Gyn, and Genetics.

Times

Check in for the conferences will begin at 8:30 am Central. Each conference will start at 9:30 am and end at 5:00 pm. Stay after the event to network with the speakers and other experts in the field.

Cost

Free! Click the links in the box on the right to register

Speakers

Rollover speaker names for detailed bios.

Carlos A. Bacino, MD

Dallas/Austin

Jeffrey P. Brosco, MD, PhD

San Antonio

Amy Brower, PhD

Dallas

Mary Esther Carlin, MD

Dallas

Debra Freedenberg, MD, PhD

Dallas/Austin/San Antonio

LaDonna Immken, MD

Austin

Laurence B. McCullough, PhD

Dallas/Austin

Scott McLean, MD

San Antonio

Beth A. Pletcher, MD, FAAP, FACMG

Austin

Angela Scheuerle, MD

Dallas

Marshall Summar MD

San Antonio

Mark T. Bedford, PhD

Austin

Joya Chandra, PhD

Austin

Katrina Dipple, MD, PhD

San Antonio

Laura Rozek, PhD

Dallas

Robert Waterland, PhD

San Antonio

Lodging

Each site has a small room block at the special conference rate. Use the registration link to the right to find more about the rates and how to reserve a hotel room.

 

This event is funded by the Texas Department of State Health Services, Contract No. 2013-042510

Contents of this site are solely the responsibility of Cardea Services and do not necessarily represent the official views of Texas DSHS.

Robert Waterland, PhD, is Associate Professor of Pediatrics and Molecular & Human Genetics, Baylor College of Medicine. Research in the Waterland laboratory aims to understand how nutrition and other environmental influences during prenatal and early postnatal development affect individual susceptibility to various diseases later in life. The research is focused on nutritional influences on developmental epigenetics as a likely mediating mechanism.

Laura Rozek, PhD, is an Assistant Professor of Public Health (Environmental Health Sciences) and Medicine (Otolaryngology) at the University of Michigan. She received a MS in Epidemiology from the University of Washington and a MA in Statistics and a PhD in Epidemiologic Sciences from the University of Michigan. Her laboratory uses molecular epidemiologic methodology to understand the contribution of environmental toxicants and diet to the development of cancer, with the goal of defining novel biomarkers for cancer prevention.

Katrina M. Dipple, MD, PhD is an Associate Professor at UCLA Medical Center. She has always been interested in biochemistry and medicine. She has a BS in Biochemistry from Indiana University in Bloomington. During her undergraduate education she became interested in genetics and decided to go to graduate school. Dr. Dipple did a combined MD/PhD degree at Indiana University School of Medicine. Her PhD is in biochemistry and molecular biology. After finishing graduate school, she came to UCLA for a pediatric residency and postdoctoral fellowship in Genetics.

Joya Chandra, PhD is an Associate Professor, Department of Pediatrics - Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston as well as Associate Professor, University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences. Research in the Chandra lab is directed towards understanding the oxidative environment of cancer cells and then using this knowledge to develop therapeutic strategies that will eliminate cancer cells.

Mark T. Bedford, PhD, is a Professor at the Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX. His lab studies the intersection between epigenetics and cancer with a specific focus on one class of epigenetic mark - arginine methylation. He received his PHD in Developmental Biology at the Weizmann Institute of Science, Israel and his Postdoctoral Fellowship, at Harvard Medical School, Boston.

Dr. Marshall Summar is the Chief of the Division of Genetics and Metabolism and the Margaret O’Malley Chair of Molecular Genetics. He joined Children's National from Vanderbilt University School of Medicine, where he directed the Program in Translational Genetics, the DNA Core program, and started the inborn errors of metabolism program. Dr. Summar is board-certified in Pediatrics, Clinical Genetics, and Biochemical Genetics. Dr. Summar serves on the editorial board of The Journal of Pediatrics and is the president-elect for the Society of Inherited Metabolic Disease. He serves on the NIH study section for the CETT program, the National Human Genetic Research Institute Fellowship Training Program Board, and the NASA radiation research review panel.

Dr. Angela Scheuerle is a Medical Geneticist: the career she wanted when she fell in love with genetics as a sophomore in high school. She received her bachelor’s degree from Sewanee: The University of the South, then continued her itinerant education with a M.D. from the University of South Florida. Dr. Scheuerle has been in private clinical practice as Tesserae Genetics since 2000. She has been at Medical City Dallas since 2003. Her patient population consists mostly of children under the age of 10 with developmental abnormalities and birth defects. She has also worked with the Texas Birth Defects Surveillance program since its inception in 1995 and is Medical Director of the Texas Center for Birth Defects Research and Prevention. She has created a birth defect classification method that is now an industry standard for pharmaceutical exposure surveillance programs. (Dallas)

Beth A. Pletcher, MD, FAAP, FACMG is an Associate Professor of Pediatrics and Medicine at the University of Medicine and Dentistry - New Jersey Medical School. Dr. Pletcher served on the Board of Directors of the American College of Medical Genetics (ACMG) for six years and she was the first Chair of the AAP Section on Genetics and Birth Defects. Dr. Pletcher is currently on the University Hospital Bioethics Committee. She is the Co-Director of The Neurofibromatosis Center of New Jersey, where more than 600 patients with neurofibromatosis receive care. Her clinical and research interests include: neurofibromatosis, autism, Fragile X syndrome, craniofacial disorders, cancer genetics, public policy on genetic screening, genetic education for primary care providers as well as pediatric workforce issues. (Austin)

Scott McLean, MD is a Clinical Geneticist at San Antonio Clinical Genetics. During 26 years on active duty in the United States Army, Dr. McLean completed his residency in Pediatrics and a fellowship in Clinical Genetics. Colonel McLean served as Consultant to the Army Surgeon General for Clinical Genetics and represented the Department of Defense on committees like the ACMG Expert Group on Newborn Screening and the Secretary's Advisory Committee on Genetics, Health, and Society. His specialty includes treating patients with nevoid basal cell carcinoma syndrome, osteogenesis imperfecta, down syndrome, congenital malformations, marfan syndrome, and neurofibromatosis. (San Antonio)

Laurence B. McCullough, PhD is the Associate Director for Education and inaugural holder (since May 2008) of the Dalton Tomlin Chair in Medical Ethics and Health Policy in the Center for Medical Ethics and Health Policy, Baylor College of Medicine, where is he also professor of Medicine and Medical Ethics. Dr. McCullough is a professor of Family and Community Medicine at Baylor and faculty associate of Baylor’s Huffington Center on Aging in Houston, TX. Dr. McCullough has published 370 papers in the peer-reviewed medical and bioethics literature. In addition, he has published 50 original chapters in scholarly books and more than 100 chapters in medical textbooks. (Dallas, Austin)

LaDonna Immken, MD is a Clinical Geneticist at ‘Specially for Children, a regional medical group that provides pediatric sub-specialty care and treatment to children and adolescents with severe, unusual and complex illnesses. She is board certified in clinical genetics and cytogenetics and a Founding Fellow of the American College of Medical Genetics and Genomics. Dr. Immken specializes in clinical and metabolic genetics in addition to pediatrics. Her special interests include Prenatal Diagnosis, Fetal Dysmorphology, and Fetal Syndromology. (Austin)

Debra Freedenberg, MD, PhD is the Medical Director of the Newborn Screening Program and Genetics at the Texas Department of State Health Services. She has experience in academic, private practice, and public health settings covering all areas of genetics practice, including prenatal, cancer genetics, metabolism, dysmorphology and intellectual disabilities. She is board certified in pediatrics, clinical genetics, clinical molecular genetics, and medical biochemical genetics. She has particular expertise in short term and long term follow up of children identified by newborn screening and serves on many national and regional committees related to newborn screening and genetic services. (Dallas, Austin, San Antonio)

Dr. Mary Esther Carlin is currently an Associate Professor in the Division of Genetics/Metabolism in the Department of Pediatrics at UT Southwestern Medical School. She runs the general Genetics and Dysmorphology as well as the multidisciplinary Down Syndrome clinics at Children’s Medical Center in Dallas. She is also in private specialty practice as Director of the Genetics and Developmental Center of the Southwest. She is interested in the ethical, legal and social implications of genetic disorders and developmental disabilities, the most effective ways to provide genetic counseling and the education of professionals and families about these topics. (Dallas)

Amy Brower, PhD, is Project Manager for the National Coordinating Center’s Long Term Follow-Up Project (NCC-LTFU) at the American College of Medical Genetics (ACMG) and Scientific Advisor in Clinical Genomics and Medicine at Aurora Health Care. Amy was a member of the Human Genome Project team. She is a former member of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) and a consultant to the Laboratory Standards & Procedures Subcommittee. Amy is a member of the CDC-sponsored Evaluation of Genomic Applications in Practice and Prevention Stakeholder’s Group (ESG), and serves on the National Advisory Council for Genetic Alliance. (Dallas)

Dr. Jeffrey P. Brosco, a Professor of Clinical Pediatrics at the University of Miami Miller School of Medicine, completed an M.D. and a Ph.D. in the history of medicine at the University of Pennsylvania. He served as chief resident after training in pediatrics at the University of Miami/Jackson Memorial Hospital, and he is board-certified in Pediatrics and in Developmental-Behavioral Pediatrics. Dr. Brosco serves as Chair of the Pediatric Bioethics Committee at Jackson Memorial Hospital and Director of Clinical Services at the Mailman Center for Child Development. He is responsible for directing both medical student and pediatric resident education regarding ethics and professionalism at the University of Miami/Jackson Health Systems. (San Antonio)

Dr. Carlos A. Bacino is a Professor at the Department of Molecular and Human Genetics, Baylor College of Medicine. In the area of clinical genetics, Dr. Bacino is involved in the diagnosis and management of patients with birth defects and a variety of genetic disorders. He participates in subspecialty clinics such as the Skeletal Dysplasia, and Craniofacial Clinics. As the Medical Director of the Kleberg Cytogenetics Laboratory, he has a particular interest in structural chromosomes abnormalities and genomic disorders (contiguous gene deletion/duplication syndromes), as well as the mechanism of origin of these chromosome anomalies. In collaboration with Dr. Arthur Beaudet and Dr. Sarika Peters, he is conducting studies for children with Angelman syndrome. (Dallas and Austin)